207 related articles for article (PubMed ID: 31931608)
1. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.
Lewis AA; Ayers CR; Selvin E; Neeland I; Ballantyne CM; Nambi V; Pandey A; Powell-Wiley TM; Drazner MH; Carnethon MR; Berry JD; Seliger SL; DeFilippi CR; de Lemos JA
Circulation; 2020 Mar; 141(12):957-967. PubMed ID: 31931608
[TBL] [Abstract][Full Text] [Related]
2. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
4. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
5. Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.
Pandey A; Keshvani N; Ayers C; Correa A; Drazner MH; Lewis A; Rodriguez CJ; Hall ME; Fox ER; Mentz RJ; deFilippi C; Seliger SL; Ballantyne CM; Neeland IJ; de Lemos JA; Berry JD
JAMA Cardiol; 2019 Jan; 4(1):51-58. PubMed ID: 30566191
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis.
Segar MW; Jaeger BC; Patel KV; Nambi V; Ndumele CE; Correa A; Butler J; Chandra A; Ayers C; Rao S; Lewis AA; Raffield LM; Rodriguez CJ; Michos ED; Ballantyne CM; Hall ME; Mentz RJ; de Lemos JA; Pandey A
Circulation; 2021 Jun; 143(24):2370-2383. PubMed ID: 33845593
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
Johnson K; Oparil S; Davis BR; Tereshchenko LG
J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
Oseni AO; Qureshi WT; Almahmoud MF; Bertoni AG; Bluemke DA; Hundley WG; Lima JA; Herrington DM; Soliman EZ
Heart; 2017 Jan; 103(1):49-54. PubMed ID: 27486144
[TBL] [Abstract][Full Text] [Related]
9. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis.
Patel KV; Segar MW; Klonoff DC; Khan MS; Usman MS; Lam CSP; Verma S; DeFilippis AP; Nasir K; Bakker SJL; Westenbrink BD; Dullaart RPF; Butler J; Vaduganathan M; Pandey A
Circulation; 2024 Jan; 149(4):293-304. PubMed ID: 37950893
[TBL] [Abstract][Full Text] [Related]
10. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study.
Okwuosa TM; Soliman EZ; Lopez F; Williams KA; Alonso A; Ferdinand KC
Am Heart J; 2015 Jan; 169(1):155-61.e5. PubMed ID: 25497261
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
13. Racial differences in incident heart failure during antihypertensive therapy.
Okin PM; Kjeldsen SE; Dahlöf B; Devereux RB
Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):157-64. PubMed ID: 21304095
[TBL] [Abstract][Full Text] [Related]
14. Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.
Iribarren C; Round AD; Lu M; Okin PM; McNulty EJ
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982671
[TBL] [Abstract][Full Text] [Related]
15. Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study.
Desai CS; Ning H; Lloyd-Jones DM
Heart; 2012 Feb; 98(4):330-4. PubMed ID: 22139711
[TBL] [Abstract][Full Text] [Related]
16. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
Ascher SB; de Lemos JA; Lee M; Wu E; Soliman EZ; Neeland IJ; Kitzman DW; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
J Am Coll Cardiol; 2022 Oct; 80(16):1516-1525. PubMed ID: 36229087
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes of cardiac troponin and inflammation reflect progressive myocyte stretch and likelihood for hypertension in a Black male cohort: The SABPA study.
Jansen van Vuren E; Malan L; von Känel R; Lammertyn L; Cockeran M; Malan NT
Hypertens Res; 2019 May; 42(5):708-716. PubMed ID: 30626934
[TBL] [Abstract][Full Text] [Related]
18. Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans.
Rautaharju PM; Park LP; Gottdiener JS; Siscovick D; Boineau R; Smith V; Powe NR
J Electrocardiol; 2000 Jul; 33(3):205-18. PubMed ID: 10954373
[TBL] [Abstract][Full Text] [Related]
19. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
[TBL] [Abstract][Full Text] [Related]
20. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
